Caspase-3 activity appears to be a major regulator of EndoG’s nuclear translocation, as evidenced by reduced nuclear EndoG expression in caspase-3-deficiency mPOR-derived tumor samples (Fig. 4C, D). This evidence concerns the gene CASP3 and neoplasm.